(R)-(+)-Dropropizine | CAS 99291-24-4 - Request Quote
(R)-(+)-Dropropizine
| SZ CAT No: | SZ-D047006 |
| CAS No | 99291-24-4 |
| Mol.F. | C13H20N2O2 |
| Mol.Wt. | 236.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
(R)-(+)-Dropropizine is chemically (R)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol. (R)-(+)-Dropropizine is supplied with detailed characterization data compliant with regulatory guideline. (R)-(+)-Dropropizine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dropropizine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 99291-24-4
Purchase 99291-24-4
Order 99291-24-4
Enquire 99291-24-4
price of 99291-24-4
99291-24-4 Supplier
99291-24-4 Manufacturer
99291-24-4 Exporter
buy high quality (R)-(+)-Dropropizine
Purchase (R)-(+)-Dropropizine
(R)-(+)-Dropropizine suppliers
(R)-(+)-Dropropizine manufacturers
(R)-(+)-Dropropizine price
Order (R)-(+)-Dropropizine
Enquire (R)-(+)-Dropropizine
(R)-(+)-Dropropizine cost
(R)-(+)-Dropropizine Supplier
(R)-(+)-Dropropizine Distributor
(R)-(+)-Dropropizine for Method Validation
Dropropizine Reference Standard
(R)-(+)-Dropropizine for ANDA Filing
(R)-(+)-Dropropizine for Forced Degradation Studies
(R)-(+)-Dropropizine Identification Standards
(R)-(+)-Dropropizine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.